
Slovenia’s role in the global pharmaceutical supply chain
Switzerland’s becoming increasingly dependent on Slovenia’s pharmaceutical industries. For decades, Novartis and Sandoz have been investing large sums of money into the Balkan nation, turning into a key partner for development and manufacturing of both innovative and copycat drugs.

More
Swiss pharma’s big bet on Slovenia
Edited by Nerys Avery and Marius Grieder.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.